The US Food and Drug Administration has approved RSV to combat the infection that kills babies
health by Brock Steinberg July 18, 2023 | 11:26 a.m The Food and Drug Administration on Monday approved a new drug, Beyfortus (nirsevimab), to protect young children from the deadly infection known as respiratory syncytial virus. Worldwide, RSV is the second leading cause of death during a newborn’s first year of life, second only to … Read more